Showing all 4 results

  • Bromocriptin Tablets
    In Stock

    Bromocriptin Tablets

    Free

    Bromocriptin Mesylate Tablets IP 2.5 MG
    Each uncoated tablet contains
    Bromocriptin Mesylate IP
    eq.to Bromocriptine 2.5 mg

    Usage: – high levels of a natural substance prolactin in the body

    Category: – Anti Parkinson drugs

    Therapeutic category: – Anti Parkinson

  • Placeholder
    In Stock

    Cabergoline Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Compressed, Micro-Dose Tablet, packed in high-barrier Alu-Alu blister strips or specialized glass vials to ensure the stability of the active API.

    Active IngredientStrengthPrimary Clinical Function
    Cabergoline USP/Ph.Eur.0.5 mgThe Standard Specialty Anchor: The definitive therapeutic unit for managing prolactin-related infertility and pituitary tumors.
    ExcipientsProprietary MatrixMicro-Gram Content Uniformity: Engineered utilizing Geometric Dilution techniques to ensure every 0.5 mg tablet contains the exact clinical dose across the entire batch.
  • Placeholder
    In Stock

    Pramipexole Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended Uncoated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly light-sensitive dihydrochloride monohydrate salt.

    Active IngredientStrengthPrimary Clinical Function
    Pramipexole (as Dihydrochloride Monohydrate) Ph.Eur./USP0.125 mgMicro-Dose Standard: Mandatory initiation unit to prevent orthostatic shock, and the gold-standard maintenance dose for RLS.
    Pramipexole (as Dihydrochloride Monohydrate) Ph.Eur./USP0.25 mg / 0.5 mgTitration Standard: Mid-level doses for the gradual, safe escalation of Parkinson’s therapy.
    Pramipexole (as Dihydrochloride Monohydrate) Ph.Eur./USP1 mgAdvanced PD Standard: High-dose maintenance therapy for severe, refractory Parkinson’s Disease.
    ExcipientsMannitol / Maize Starch / Povidone K25 / Colloidal Silicon Dioxide / Magnesium StearateDiluent / Binder / Glidant / Lubricant (Engineered for immediate gastric dissolution and rapid, highly predictable systemic absorption)

    *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict, high-compliance chronic neurology dispensing and complex titration regimens).

  • Placeholder
    In Stock

    Ropinirole Extended-Release

    Free

    Product Composition & Strength

    We supply this product as a Precision-Engineered Polymeric Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute stability of the modified-release polymers.

    Active IngredientStrengthPrimary Clinical Function
    Ropinirole HCl USP/Ph.Eur.2 mg / 4 mgBase titration units for the slow, safe initiation of dopaminergic therapy.
    Ropinirole HCl USP/Ph.Eur.8 mgGlobal Clinical Standard: Advanced maintenance dose for 24-hour continuous symptom control. (Higher total daily doses may be required).
    ExcipientsHypromellose (HPMC) / Carmellose Sodium / Lactose Monohydrate / Magnesium StearateHydrophilic Polymer Matrix / Diluent / Lubricant (Engineered to form a viscous gel layer that controls the strict 24-hour drug diffusion rate)

    *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 28/30 (Optimized specifically for strict 30-day chronic neurology dispensing regimens).